183 related articles for article (PubMed ID: 8805743)
1. Gamma imaging of atherosclerotic lesions: the role of antibody affinity in in vivo target localization.
Narula J; Petrov A; O'Donnell SM; Ditlow C; Pieslak I; Dilley J; Chen F; Khaw BA
J Nucl Cardiol; 1996; 3(3):231-41. PubMed ID: 8805743
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA
Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
[TBL] [Abstract][Full Text] [Related]
4. Maximizing radiotracer delivery to experimental atherosclerotic lesions with high-dose, negative charge-modified Z2D3 antibody for immunoscintigraphic targeting.
Narula J; Petrov A; Ditlow C; Pak KY; Chen FW; Khaw BA
J Nucl Cardiol; 1997; 4(3):226-33. PubMed ID: 9199260
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells.
Carrió I; Pieri PL; Narula J; Prat L; Riva P; Pedrini L; Pretolani E; Caruso G; Sarti G; Estorch M; Berná L; Riambau V; Matías-Guiu X; Pak C; Ditlow C; Chen F; Khaw BA
J Nucl Cardiol; 1998; 5(6):551-7. PubMed ID: 9869476
[TBL] [Abstract][Full Text] [Related]
6. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
[TBL] [Abstract][Full Text] [Related]
7. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.
Tsimikas S; Palinski W; Halpern SE; Yeung DW; Curtiss LK; Witztum JL
J Nucl Cardiol; 1999; 6(1 Pt 1):41-53. PubMed ID: 10070840
[TBL] [Abstract][Full Text] [Related]
9. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
Buchsbaum DJ; Brubaker PG; Hanna DE; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z
Cancer Res; 1990 Feb; 50(3 Suppl):993s-999s. PubMed ID: 2297753
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
11. Smooth muscle cell proliferation index correlates with 111In-labeled antibody Z2D3 uptake in a transplant vasculopathy swine model.
Jimenez J; Donahay T; Schofield L; Khaw BA; Johnson LL
J Nucl Med; 2005 Mar; 46(3):514-9. PubMed ID: 15750167
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection.
Dadachova E; Bryan RA; Huang X; Ortiz G; Moadel T; Casadevall A
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5629s-5635s. PubMed ID: 17875799
[TBL] [Abstract][Full Text] [Related]
13. Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
Khawli LA; Alauddin MM; Hu P; Epstein AL
Cancer Biother Radiopharm; 2003 Dec; 18(6):931-40. PubMed ID: 14969605
[TBL] [Abstract][Full Text] [Related]
14. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
Peräalä-Heape M; Vihko P; Vihko R
Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168
[TBL] [Abstract][Full Text] [Related]
15. Different behaviour of mouse-human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub-class in vivo.
Buchegger F; Pèlegrin A; Hardman N; Heusser C; Lukas J; Dolci W; Mach JP
Int J Cancer; 1992 Feb; 50(3):416-22. PubMed ID: 1735611
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunodetection of human tumor xenografts by monoclonal antibody F(ab')2 fragments.
Herlyn D; Powe J; Munz DL; Alavi A; Herlyn M; Meinken GE; Srivastava SC; Koprowski H
Int J Rad Appl Instrum B; 1986; 13(4):401-5. PubMed ID: 3793494
[TBL] [Abstract][Full Text] [Related]
17. Immunoscintigraphic detection of primary and metastatic spontaneous canine osteosarcoma with F(ab')2 fragments of osteosarcoma-associated monoclonal antibody TP-1.
Haines DM; Bruland OS; Matte G; Wilkinson AA; Meric SM; Fowler JD
Anticancer Res; 1992; 12(6B):2151-7. PubMed ID: 1295462
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
